IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,514 | -80.5% | 44,394 | -78.5% | 0.00% | -80.0% |
| Q2 2023 | $2,197,755 | +7.1% | 206,556 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $2,052,000 | -12.9% | 195,057 | +2.5% | 0.01% | -16.7% |
| Q4 2022 | $2,357,234 | -10.0% | 190,253 | -24.7% | 0.01% | -14.3% |
| Q3 2022 | $2,618,000 | +156.7% | 252,692 | +185.7% | 0.01% | +250.0% |
| Q2 2022 | $1,020,000 | -8.4% | 88,444 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,113,000 | -67.5% | 88,454 | -69.9% | 0.00% | -66.7% |
| Q4 2021 | $3,429,000 | +1.8% | 294,059 | +14.0% | 0.01% | -14.3% |
| Q3 2021 | $3,368,000 | -4.2% | 257,902 | -5.6% | 0.01% | 0.0% |
| Q2 2021 | $3,516,000 | +252.3% | 273,209 | +206.1% | 0.01% | +250.0% |
| Q1 2021 | $998,000 | -1.9% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,017,000 | +26.7% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $803,000 | -12.8% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $921,000 | +2.2% | 89,266 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $901,000 | -24.2% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,188,000 | +55.1% | 89,266 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $766,000 | -21.6% | 89,266 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $977,000 | -19.1% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,208,000 | +30.6% | 89,266 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $925,000 | -43.9% | 89,266 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $1,648,000 | -3.5% | 89,266 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $1,707,000 | +25.6% | 89,266 | +1.4% | 0.01% | +25.0% |
| Q1 2018 | $1,359,000 | +3.0% | 88,066 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,320,000 | -5.0% | 88,066 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,389,000 | -16.5% | 88,066 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $1,663,000 | +10.7% | 88,066 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $1,502,000 | +11.5% | 88,066 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,347,000 | -3.6% | 88,066 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,398,000 | +21.5% | 88,066 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,151,000 | +20.4% | 88,066 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $956,000 | -5.6% | 87,403 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,013,000 | +11.2% | 87,403 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $911,000 | -13.6% | 87,403 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,054,000 | -24.6% | 87,403 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $1,398,000 | +5.8% | 87,403 | +1.3% | 0.01% | +25.0% |
| Q4 2014 | $1,321,000 | +18.3% | 86,257 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,117,000 | -15.5% | 86,257 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,322,000 | +50.2% | 86,257 | +20.8% | 0.00% | +33.3% |
| Q1 2014 | $880,000 | +6.2% | 71,401 | 0.0% | 0.00% | +50.0% |
| Q4 2013 | $829,000 | -2.0% | 71,401 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $846,000 | +19.3% | 71,401 | +0.2% | 0.00% | +50.0% |
| Q2 2013 | $709,000 | – | 71,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |